Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213909869> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W3213909869 abstract "Introduction: Annamycin (ANN) is a non-cardiotoxic potent topoisomerase II poison that is structurally related to doxorubicin (Dox) but it displays significantly different biological properties. ANN is formulated in multilamellar liposomes to enable effective in vivo administration as L-ANN. Pancreatic ductal adenocarcinoma (PDAC) represents a major challenge and is the deadliest cancer in decades. Pancreas drug uptake and retention remains a significant factor contributing to the chemoresistance of PDAC. Additionally, drug resistance on a cellular level further limits the therapeutic options for pancreatic cancer patients. Based on unique biological properties, we select L-ANN for detailed characterization of anti-tumor potency in preclinical PDAC models. Objective: The objective of this study was to validate the L-ANN exceptional uptake in pancreatic cancer cells and tumors and explore its high pancreas uptake to target PDACs by assessing the efficacy of L-ANN in the preclinical mouse models. Methods: The uptake, cytotoxicity, and L-ANN-induced apoptosis were studied in human MDA-PATC50 and MDA-PATC53 cell lines. L-ANN pharmacokinetics and tissue-organ distribution were analyzed in CD-1 mice after bolus administration of L-ANN, ANN or DOX. Subcutaneous and orthotopic MDA-PATC50 and MDA-PATC53 mouse models were used to assess activity of L-ANN in vivo. Results: Fluorescent microscopy and FACS analysis showed significantly higher uptake of ANN in MDA-PATC50 and MDA-PATC53 when compared to DOX-treated cells. Interestingly, ANN displayed distinct subcellular distribution with predominantly cytosolic localization. Average IC50 of ANN or DOX treated MDA-PATC50 and MDA-PATC53 cells were 25.1 nM and 41.9 nM for ANN and 32.8 nM and 130.4 nM for DOX respectively (72h exposure). Biodistribution study showed rapid L-Ann absorption in the pancreas. The Cmax of L-Ann was 15-fold higher than Dox after administration of L-ANN or Dox (both at 4 mg/kg) in pancreatic tissue. The subcutaneous models demonstrated dose-dependent reduction in tumor volumes after 3 doses of L-Ann in both PDAC models. Additionally, efficacy of L-ANN was assessed in two orthotopic PDAC models. MRI confirmed tumor volume reduction in L-Ann 3 mg/kg and 4 mg/kg doses in MDA-PATC50 model (p<0.05 for both 3 and 4 mg), and in MDA-PATC53 model (p<0.001 and p<0.0001, respectively). The median survivals (MS) were 135 and 103 days for L-Ann at 3 mg/kg and 4 mg/kg respectively (MS for vehicle was 49 days, p<0.0001). MDA-PATC50 orthotopic model demonstrated the similar results (ongoing study). Conclusion: Annamycin exhibits high and rapid uptake in the pancreatic cancer cells and in pancreas itself when compared to Dox. Subsequently, ANN appeared to be highly cytotoxic against tested pancreatic cancer cell lines and as L-ANN potently inhibits tumor growth and increase survival in experimental models of pancreatic cancer. These experiments demonstrate remarkable activity of L-ANN in PDAC models and support future clinical studies.Citation Format: Ya'an Kang, Rafal Zielinski, Roberto Cardenas Zuniga, Radjendirane Venugopal, Maria Poimenidou, Magdalena Remiszewski, Shaohua Peng, Edd Felix, Krzysztof Grela, Stanislaw Skora, Van N. Nguyen, Izabela Fokt, Waldemar Priebe. High uptake, retention, and in vivo activity of L-Annamycin in pancreatic cancer models [abstract]. In: Proceedings of the AACR Virtual Special Conference on Pancreatic Cancer; 2021 Sep 29-30. Philadelphia (PA): AACR; Cancer Res 2021;81(22 Suppl):Abstract nr PO-066." @default.
- W3213909869 created "2021-11-22" @default.
- W3213909869 creator A5001866182 @default.
- W3213909869 creator A5003828441 @default.
- W3213909869 creator A5005883777 @default.
- W3213909869 creator A5010943265 @default.
- W3213909869 creator A5012543447 @default.
- W3213909869 creator A5013970493 @default.
- W3213909869 creator A5024959960 @default.
- W3213909869 creator A5037204376 @default.
- W3213909869 creator A5053004154 @default.
- W3213909869 creator A5054388259 @default.
- W3213909869 creator A5055645760 @default.
- W3213909869 creator A5062959791 @default.
- W3213909869 creator A5068136509 @default.
- W3213909869 date "2021-11-15" @default.
- W3213909869 modified "2023-09-27" @default.
- W3213909869 title "Abstract PO-066: High uptake, retention, and in vivo activity of L-Annamycin in pancreatic cancer models" @default.
- W3213909869 doi "https://doi.org/10.1158/1538-7445.panca21-po-066" @default.
- W3213909869 hasPublicationYear "2021" @default.
- W3213909869 type Work @default.
- W3213909869 sameAs 3213909869 @default.
- W3213909869 citedByCount "0" @default.
- W3213909869 crossrefType "proceedings-article" @default.
- W3213909869 hasAuthorship W3213909869A5001866182 @default.
- W3213909869 hasAuthorship W3213909869A5003828441 @default.
- W3213909869 hasAuthorship W3213909869A5005883777 @default.
- W3213909869 hasAuthorship W3213909869A5010943265 @default.
- W3213909869 hasAuthorship W3213909869A5012543447 @default.
- W3213909869 hasAuthorship W3213909869A5013970493 @default.
- W3213909869 hasAuthorship W3213909869A5024959960 @default.
- W3213909869 hasAuthorship W3213909869A5037204376 @default.
- W3213909869 hasAuthorship W3213909869A5053004154 @default.
- W3213909869 hasAuthorship W3213909869A5054388259 @default.
- W3213909869 hasAuthorship W3213909869A5055645760 @default.
- W3213909869 hasAuthorship W3213909869A5062959791 @default.
- W3213909869 hasAuthorship W3213909869A5068136509 @default.
- W3213909869 hasConcept C109316439 @default.
- W3213909869 hasConcept C110121322 @default.
- W3213909869 hasConcept C121608353 @default.
- W3213909869 hasConcept C126322002 @default.
- W3213909869 hasConcept C134306372 @default.
- W3213909869 hasConcept C150903083 @default.
- W3213909869 hasConcept C185592680 @default.
- W3213909869 hasConcept C190283241 @default.
- W3213909869 hasConcept C202751555 @default.
- W3213909869 hasConcept C207001950 @default.
- W3213909869 hasConcept C2776694085 @default.
- W3213909869 hasConcept C2777292972 @default.
- W3213909869 hasConcept C2778764654 @default.
- W3213909869 hasConcept C2780210213 @default.
- W3213909869 hasConcept C2781303535 @default.
- W3213909869 hasConcept C33923547 @default.
- W3213909869 hasConcept C502942594 @default.
- W3213909869 hasConcept C55493867 @default.
- W3213909869 hasConcept C71924100 @default.
- W3213909869 hasConcept C86803240 @default.
- W3213909869 hasConcept C96232424 @default.
- W3213909869 hasConcept C98274493 @default.
- W3213909869 hasConceptScore W3213909869C109316439 @default.
- W3213909869 hasConceptScore W3213909869C110121322 @default.
- W3213909869 hasConceptScore W3213909869C121608353 @default.
- W3213909869 hasConceptScore W3213909869C126322002 @default.
- W3213909869 hasConceptScore W3213909869C134306372 @default.
- W3213909869 hasConceptScore W3213909869C150903083 @default.
- W3213909869 hasConceptScore W3213909869C185592680 @default.
- W3213909869 hasConceptScore W3213909869C190283241 @default.
- W3213909869 hasConceptScore W3213909869C202751555 @default.
- W3213909869 hasConceptScore W3213909869C207001950 @default.
- W3213909869 hasConceptScore W3213909869C2776694085 @default.
- W3213909869 hasConceptScore W3213909869C2777292972 @default.
- W3213909869 hasConceptScore W3213909869C2778764654 @default.
- W3213909869 hasConceptScore W3213909869C2780210213 @default.
- W3213909869 hasConceptScore W3213909869C2781303535 @default.
- W3213909869 hasConceptScore W3213909869C33923547 @default.
- W3213909869 hasConceptScore W3213909869C502942594 @default.
- W3213909869 hasConceptScore W3213909869C55493867 @default.
- W3213909869 hasConceptScore W3213909869C71924100 @default.
- W3213909869 hasConceptScore W3213909869C86803240 @default.
- W3213909869 hasConceptScore W3213909869C96232424 @default.
- W3213909869 hasConceptScore W3213909869C98274493 @default.
- W3213909869 hasLocation W32139098691 @default.
- W3213909869 hasOpenAccess W3213909869 @default.
- W3213909869 hasPrimaryLocation W32139098691 @default.
- W3213909869 hasRelatedWork W1980030999 @default.
- W3213909869 hasRelatedWork W1982027601 @default.
- W3213909869 hasRelatedWork W2045698890 @default.
- W3213909869 hasRelatedWork W2094219250 @default.
- W3213909869 hasRelatedWork W2356819743 @default.
- W3213909869 hasRelatedWork W2416964709 @default.
- W3213909869 hasRelatedWork W2464301138 @default.
- W3213909869 hasRelatedWork W2525456170 @default.
- W3213909869 hasRelatedWork W2949951199 @default.
- W3213909869 hasRelatedWork W3151701550 @default.
- W3213909869 isParatext "false" @default.
- W3213909869 isRetracted "false" @default.
- W3213909869 magId "3213909869" @default.
- W3213909869 workType "article" @default.